secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2024-04-12T23:59:59+00:00
Accession:  0001193125-24-094701
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex receives Nasdaq notice for failing minimum equity requirement
----------------------------------------------------------------------

- Nasdaq notice on April 11, 2024: Vaccinex lacks $2.5M minimum stockholders' equity for continued listing.
- Company also fails alternative standards: market value of listed securities $35M or net income $500k.
- Deadline to submit compliance plan is May 13, 2024; Nasdaq may grant extension if plan accepted.
- No immediate delisting, but failure to regain compliance could lead to delisting of VCNX common stock.
- Management evaluating options but cannot assure regaining or maintaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524094701/0001193125-24-094701-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524094701/d719945d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-094701

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer